We conducted in vitro and in vivo studies to investigate the effect of PD2 on the autophagy and senescence of HCC cells, providing a theoretical basis for the future development of anti-tumor drugs based on PD2. The gene discussed is PAF1; the disease is hepatocellular carcinoma.